Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 3Unknown 2Recruiting 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Myeloid 2

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × OTHER × Mast Cell Activation Disorders × Clear all
NCT04978740 2022-12-01

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

Poitiers University Hospital

Phase NA Completed
21 enrolled

Mast Cell Activation Syndrome, Mast Cell Activation Disorders, Urticaria Pigmentosa

NCT00336076 2016-11-07

Molecular Mechanisms and Diagnosis of Mastocytosis

University of Michigan

Completed
136 enrolled
Myeloid

Mast Cell Activation Disorders, Anaphylaxis, Mastocytosis, Piebaldism

NCT01297777 2016-08-29

Imatinib in KIT-negative Systemic Mastocytosis

Hospital Virgen de la Salud

Phase 4 Completed
10 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡